Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6120519 | Journal of Clinical Virology | 2014 | 6 Pages |
Abstract
Telbivudine and lamivudine can reduce HBV DNA levels in pregnant women, interrupt the vertical transmission of HBV and be used safely in mothers and children.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Min-Min Yu, Qian Jiang, Ying Ji, Kai-Hua Wu, Li-Li Ju, Xun Tang, Yong-Feng Yang,